Komen Louisiana will hold its inaugural Metastatic Breast Cancer (MBC) Conference on Saturday, June 8, 2019, at Pennington Biomedical Research Center Conference Center in Baton Rouge. The event is from 8 a.m. to 5 p.m. and is free and open to those living with metastatic breast cancer and their family and friend caregivers. The daylong event provides discussions on emerging research, …
UH Cancer Center, HMSA collaborate to fight breast cancer
By: Nana Ohkawa From: hawaii.edu The University of Hawaiʻi Cancer Center is working with the Hawaiʻi Medical Service Association (HMSA) to conduct a first-of-its-kind clinical trial that could lead to less anxiety for patients with metastatic breast cancer, improved quality of life for patients and their families and lower costs for the community. These changes would result from optimizing the …
New role for a driver of metastatic cancers
Source: Salk Institute for Biological Studies From: prnewswire.com Salk scientists uncover the mechanism of a gene to better target cancer therapy Metastatic ovarian, prostate and breast cancers are notoriously difficult to treat and often deadly. Now, Salk Institute researchers have revealed a new role for the CDK12 protein. The findings were published in the print version of Genes & Development …
New Study Shows a Decline in the Incidence of Recurrent Metastatic Breast Cancer Over Time but no Improvement in Survival
From: prnewswire.com A retrospective analysis – reported in the journal Breast Cancer Research and Treatment, by Judith Malmgren, PhD, and co-authors – studied 8292 women with stage I-III invasive breast cancer, 964 of whom (11.6%) were later diagnosed with recurrent metastatic breast cancer (rMBC). The authors found a significant decline in rMBC over time, but no increase in survival. Survival …
What happens when breast cancer metastasizes in the lungs?
By: Jamie Eske From: medicalnewstoday.com Metastatic is a term that refers to cancer that has spread outside of the original area to a different place in the body. Metastatic breast cancer in the lungs refers to cancer that originally developed inside the breast tissue but has spread to the lungs. Breast cancer is the most common form of cancer among …
Fibrosis-targeting drugs may benefit patients with late-stage, metastatic breast cancer
Source: massgeneral.org From: news-medical.net A Massachusetts General Hospital (MGH) research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer. Their report published in PNAS also finds that plerixafor, a drug approved to mobilize blood system stem cells in the treatment of lymphoma and multiple myeloma patients, can reduce fibrosis …
Royal United Hospital in Bath leads UK in new worldwide breast cancer trial
From: bathecho.co.uk The RUH in Bath has become the first site in the UK and Europe to recruit a patient to a worldwide study, testing a new combination of drugs to treat breast cancer. Dr Rebecca Bowen, RUH Consultant Medical Oncologist, who is leading the research study at the hospital, said: “We are delighted to be participating in such an …
Fred Hutch researchers root out sleeping breast cancer cells to stop metastasis
By: James Thorne From: geekwire.com Researchers at the Fred Hutchinson Cancer Research Center led by Dr. Cyrus Ghajar recently uncovered promising new science in the battle against metastatic breast cancer. Their findings, published today in Nature Cell Biology, show that it’s possible to destroy cancer cells that can hide for years in people’s bone marrow. Chemotherapy is often effective at …
Cancer: Drug fights formation of metastasis
Source: University of Basel From: sciencedaily.com The most deadly aspect of breast cancer is metastasis. It spreads cancer cells throughout the body. Researchers at the University and the University Hospital of Basel have now discovered a substance that suppresses the formation of metastases. In the journal Cell, the team of molecular biologists, computational biologists, and clinicians reports on their interdisciplinary …
Athenex Announces Completion of Target Enrollment in the Oraxol Phase III Study
By: GlobeNewswire From: nasdaq.com Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that target enrollment of 360 patients in the Oraxol Phase III clinical trial in metastatic breast cancer has been achieved on schedule. Athenex also reaffirms that top line data from …